.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Rome IV represents a major evolution in the understanding of functional gastrointestinal disorders, now conceptualized more broadly as disorders of gut–brain interaction. The framework integrates altered motility, visceral hypersensitivity, mucosal and immune changes, gut microbiota and central nervous system processing into a biopsychosocial model. Diagnostic criteria were refined for disorders such as irritable bowel syndrome and functional dyspepsia, with greater emphasis on bothersome symptoms and clinically useful subtyping. For internists, the practical challenge is to avoid both extremes: dismissing symptoms as “functional” without appropriate evaluation, or repeatedly investigating patients after relevant organic disease has been reasonably excluded. A structured history, alarm-feature assessment and symptom-based diagnostic framework can reduce unnecessary testing while improving therapeutic focus. Treatment can include dietary measures, behavioral interventions, neuromodulators and symptom-specific pharmacotherapy. The Rome IV model also recognizes the importance of the patient experience and doctor–patient communication. This makes the topic particularly appropriate for a conference themed around medical science and humanity, where accurate diagnosis and empathetic explanation need to work together.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Rome IV represents a major evolution in the understanding of functional gastrointestinal disorders, now conceptualized more broadly as disorders of gut–brain interaction. The framework integrates altered motility, visceral hypersensitivity, mucosal and immune changes, gut microbiota and central nervous system processing into a biopsychosocial model. Diagnostic criteria were refined for disorders such as irritable bowel syndrome and functional dyspepsia, with greater emphasis on bothersome symptoms and clinically useful subtyping. For internists, the practical challenge is to avoid both extremes: dismissing symptoms as “functional” without appropriate evaluation, or repeatedly investigating patients after relevant organic disease has been reasonably excluded. A structured history, alarm-feature assessment and symptom-based diagnostic framework can reduce unnecessary testing while improving therapeutic focus. Treatment can include dietary measures, behavioral interventions, neuromodulators and symptom-specific pharmacotherapy. The Rome IV model also recognizes the importance of the patient experience and doctor–patient communication. This makes the topic particularly appropriate for a conference themed around medical science and humanity, where accurate diagnosis and empathetic explanation need to work together.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
